Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Gregory Schwartz

Concepts (580)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
72
2025
279
16.430
 Why?
Anticholesteremic Agents
53
2025
153
12.730
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
56
2024
445
7.910
 Why?
Lipoprotein(a)
21
2025
67
7.580
 Why?
Antibodies, Monoclonal, Humanized
41
2025
804
6.710
 Why?
Cholesterol, LDL
52
2025
365
6.360
 Why?
Myocardial Infarction
44
2023
1046
5.120
 Why?
Cardiovascular Diseases
39
2024
2111
4.340
 Why?
Proprotein Convertase 9
26
2025
73
3.560
 Why?
Coronary Disease
16
2020
385
3.190
 Why?
Angina, Unstable
19
2019
76
2.890
 Why?
Heptanoic Acids
23
2016
66
2.720
 Why?
Cholesterol, HDL
13
2020
203
2.700
 Why?
Diabetes Mellitus, Type 2
23
2025
2531
2.660
 Why?
Sulfhydryl Compounds
10
2020
189
2.550
 Why?
Pyrroles
23
2016
213
2.520
 Why?
Hypercholesterolemia
11
2023
106
2.500
 Why?
Stroke
31
2023
1120
2.410
 Why?
Dyslipidemias
8
2024
176
2.370
 Why?
Quinazolinones
7
2021
19
2.210
 Why?
Serine Proteinase Inhibitors
5
2025
47
1.970
 Why?
Myocardial Ischemia
17
2018
263
1.680
 Why?
Secondary Prevention
11
2019
233
1.620
 Why?
Thiazolidinediones
10
2017
137
1.610
 Why?
Atherosclerosis
11
2024
415
1.590
 Why?
Cholesterol
12
2022
410
1.570
 Why?
Double-Blind Method
42
2024
1993
1.560
 Why?
Treatment Outcome
64
2025
10811
1.450
 Why?
Esters
9
2020
76
1.410
 Why?
Amides
9
2020
93
1.400
 Why?
Oxazoles
8
2019
37
1.390
 Why?
Cholesterol Ester Transfer Proteins
5
2016
20
1.350
 Why?
Hypoglycemic Agents
18
2024
1291
1.330
 Why?
Thiophenes
8
2019
117
1.310
 Why?
Risk Factors
45
2024
10388
1.290
 Why?
Aged
79
2025
23961
1.260
 Why?
Myocardial Contraction
14
2013
341
1.190
 Why?
Ventricular Fibrillation
3
2017
60
1.180
 Why?
Middle Aged
83
2025
33479
1.180
 Why?
Humans
171
2025
137585
1.170
 Why?
Swine
35
2023
775
1.160
 Why?
Coronary Artery Disease
6
2023
698
1.140
 Why?
C-Reactive Protein
11
2022
410
1.120
 Why?
Risk Assessment
20
2024
3457
1.120
 Why?
Insulin Resistance
10
2018
1208
1.110
 Why?
Antibodies, Monoclonal
7
2023
1430
1.080
 Why?
Myocardium
23
2004
1002
1.050
 Why?
Metabolic Syndrome
4
2013
354
1.040
 Why?
Diabetic Angiopathies
2
2019
259
1.040
 Why?
Male
106
2025
67762
1.030
 Why?
Female
112
2025
73304
0.960
 Why?
Myocardial Reperfusion Injury
5
2013
135
0.960
 Why?
Ischemic Attack, Transient
6
2018
65
0.950
 Why?
Lipoproteins, HDL
4
2019
77
0.910
 Why?
Heart
10
2009
655
0.910
 Why?
PPAR gamma
6
2022
182
0.890
 Why?
Proteins
3
2020
1009
0.880
 Why?
Proprotein Convertases
2
2014
16
0.850
 Why?
Peripheral Arterial Disease
3
2020
475
0.850
 Why?
RNA, Small Interfering
10
2024
622
0.820
 Why?
Triglycerides
5
2024
524
0.810
 Why?
Biomarkers
22
2025
4149
0.760
 Why?
Fatty Acids, Nonesterified
4
2018
159
0.730
 Why?
Insulin
7
2021
2409
0.710
 Why?
Patient Admission
2
2021
197
0.710
 Why?
Time Factors
21
2024
6828
0.700
 Why?
Coronary Circulation
18
2004
143
0.690
 Why?
Cardiovascular Agents
4
2021
159
0.670
 Why?
Molecular Targeted Therapy
2
2014
411
0.670
 Why?
Hospitalization
5
2019
2199
0.670
 Why?
Randomized Controlled Trials as Topic
18
2024
1477
0.650
 Why?
Recurrence
11
2021
1060
0.640
 Why?
Hyperlipoproteinemia Type II
3
2025
35
0.630
 Why?
Energy Metabolism
13
2004
922
0.600
 Why?
Renal Insufficiency, Chronic
5
2025
617
0.590
 Why?
Swine, Miniature
3
2013
82
0.580
 Why?
Adiponectin
2
2018
244
0.570
 Why?
Lipid Metabolism
2
2014
518
0.570
 Why?
Heart Arrest
4
2017
339
0.560
 Why?
Venous Thrombosis
1
2020
190
0.560
 Why?
Brain Ischemia
5
2022
338
0.560
 Why?
Ezetimibe
4
2023
24
0.550
 Why?
Aldosterone
1
2017
45
0.530
 Why?
Rosuvastatin Calcium
4
2022
22
0.520
 Why?
Cardiovascular System
1
2018
137
0.510
 Why?
Venous Thromboembolism
1
2020
316
0.490
 Why?
Arteriosclerosis
2
2014
88
0.460
 Why?
Patient Readmission
2
2021
697
0.460
 Why?
Adenosine Triphosphate
14
2017
491
0.440
 Why?
Drug Therapy, Combination
6
2020
1066
0.440
 Why?
Magnetic Resonance Spectroscopy
17
2019
611
0.420
 Why?
Diabetes Complications
3
2021
227
0.410
 Why?
Metformin
1
2017
331
0.410
 Why?
Animals
49
2023
36940
0.400
 Why?
Phosphocreatine
13
1995
46
0.390
 Why?
Atrial Fibrillation
2
2022
388
0.390
 Why?
Veterans
3
2023
1476
0.390
 Why?
Phosphates
7
2024
182
0.390
 Why?
Hemodynamics
11
2007
1113
0.380
 Why?
Ventricular Function, Left
9
2004
534
0.380
 Why?
Proportional Hazards Models
9
2019
1266
0.380
 Why?
Heart Failure
9
2022
2236
0.380
 Why?
Coronary Vessels
8
2012
248
0.370
 Why?
Blood Pressure
11
2012
1786
0.370
 Why?
Obesity
3
2024
2992
0.370
 Why?
Uncertainty
1
2012
128
0.360
 Why?
Dietary Fats
2
2013
304
0.360
 Why?
Drug Administration Schedule
8
2019
786
0.340
 Why?
Follow-Up Studies
11
2023
5131
0.340
 Why?
Glucose
5
2020
1020
0.340
 Why?
Reperfusion Injury
2
2005
279
0.340
 Why?
Systole
7
2001
189
0.340
 Why?
Fluorobenzenes
2
2014
16
0.340
 Why?
Phospholipases A2, Secretory
4
2014
12
0.320
 Why?
Risk
9
2018
912
0.320
 Why?
Research Design
3
2009
1139
0.320
 Why?
Diastole
5
2001
149
0.310
 Why?
Ischemia
1
2012
409
0.300
 Why?
Ventricular Dysfunction, Right
3
2007
238
0.300
 Why?
Surgical Procedures, Operative
4
2017
259
0.290
 Why?
KATP Channels
1
2008
20
0.290
 Why?
Apolipoproteins B
5
2022
43
0.280
 Why?
Cohort Studies
6
2023
5742
0.280
 Why?
Clinical Trials, Phase III as Topic
3
2024
106
0.280
 Why?
Chromans
3
2004
25
0.280
 Why?
Acute Disease
9
2012
1007
0.280
 Why?
Hypolipidemic Agents
3
2022
91
0.270
 Why?
Mortality
3
2017
362
0.270
 Why?
Survival Analysis
7
2018
1325
0.270
 Why?
Peptide Fragments
4
2024
706
0.270
 Why?
Incidence
7
2022
2804
0.270
 Why?
Dose-Response Relationship, Drug
7
2019
2057
0.270
 Why?
Veterans Health
2
2020
186
0.260
 Why?
Potassium
2
2014
147
0.260
 Why?
Cholecalciferol
1
2007
60
0.260
 Why?
Sodium
2
2020
217
0.260
 Why?
Pyrimidines
2
2014
470
0.260
 Why?
Prognosis
6
2024
4030
0.250
 Why?
Sulfonamides
2
2014
513
0.250
 Why?
Diet
3
2025
1278
0.250
 Why?
Phospholipids
3
2018
223
0.250
 Why?
Subtilisins
2
2023
10
0.250
 Why?
Hyperlipoproteinemia Type III
1
2025
3
0.240
 Why?
Fenofibrate
1
2005
28
0.240
 Why?
Myelodysplastic Syndromes
1
2007
135
0.230
 Why?
Dobutamine
5
2000
39
0.230
 Why?
Oxygen Consumption
8
2000
696
0.230
 Why?
Acetates
3
2019
99
0.230
 Why?
Disease Models, Animal
8
2013
4295
0.230
 Why?
Blood Glucose
6
2024
2186
0.230
 Why?
Apolipoprotein A-I
2
2018
30
0.230
 Why?
Natriuretic Peptide, Brain
3
2024
99
0.230
 Why?
Prediabetic State
2
2020
253
0.220
 Why?
Cardiotonic Agents
3
2005
124
0.220
 Why?
Lanthanum
1
2024
13
0.220
 Why?
Adrenergic beta-Antagonists
3
2013
323
0.220
 Why?
Morbidity
5
2017
324
0.220
 Why?
Hyperemia
3
1991
49
0.220
 Why?
Syndrome
6
2007
358
0.210
 Why?
Cause of Death
5
2017
434
0.210
 Why?
Injections, Subcutaneous
2
2024
157
0.210
 Why?
Thiazoles
2
2003
123
0.210
 Why?
Phosphorylation
3
2013
1759
0.200
 Why?
Serine Endopeptidases
2
2014
123
0.200
 Why?
Isoproterenol
3
1998
113
0.200
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
17
0.200
 Why?
Lipids
3
2024
672
0.200
 Why?
Residence Characteristics
3
2016
351
0.200
 Why?
Genes, Bacterial
1
2023
164
0.200
 Why?
Blood Vessels
1
2024
187
0.200
 Why?
Calcitriol
2
2003
58
0.190
 Why?
Indoles
3
2019
412
0.190
 Why?
Calcifediol
2
2000
33
0.190
 Why?
Predictive Value of Tests
5
2017
2031
0.180
 Why?
Livestock
2
2023
10
0.180
 Why?
Propensity Score
2
2021
294
0.180
 Why?
Insulin Receptor Substrate Proteins
2
2013
59
0.180
 Why?
Prostatic Neoplasms
5
2003
1043
0.180
 Why?
Diacetyl
1
2001
7
0.180
 Why?
PPAR alpha
4
2022
58
0.180
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
220
0.180
 Why?
Cost-Benefit Analysis
2
2020
591
0.180
 Why?
Pancreatic Neoplasms
2
2000
938
0.180
 Why?
Muscles
1
2022
326
0.180
 Why?
Mental Status and Dementia Tests
1
2021
26
0.170
 Why?
Oxidative Stress
2
2025
1317
0.170
 Why?
Cytokines
2
2005
2085
0.170
 Why?
Myocardial Reperfusion
1
2000
50
0.170
 Why?
Apolipoproteins
3
2012
33
0.170
 Why?
Cataract
1
2023
213
0.170
 Why?
Coronary Artery Bypass
2
2019
234
0.170
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
82
0.160
 Why?
Lipoproteins, LDL
2
2014
116
0.160
 Why?
Calpain
2
2012
59
0.160
 Why?
Perioperative Care
2
2017
178
0.160
 Why?
Matrix Metalloproteinases
1
2000
95
0.160
 Why?
Cadmium
1
2000
69
0.160
 Why?
Oncogenes
1
2000
116
0.160
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
279
0.150
 Why?
Proto-Oncogene Proteins c-akt
2
2013
437
0.150
 Why?
Renin-Angiotensin System
1
2019
85
0.150
 Why?
Alkaline Phosphatase
1
2019
148
0.150
 Why?
United States
7
2023
14841
0.150
 Why?
Adenylyl Cyclases
2
2016
87
0.150
 Why?
Early Termination of Clinical Trials
2
2015
17
0.140
 Why?
Immunoturbidimetry
1
2018
1
0.140
 Why?
Multifactorial Inheritance
1
2019
174
0.140
 Why?
Carotid Artery Diseases
1
2018
64
0.140
 Why?
Risk Reduction Behavior
1
2020
220
0.140
 Why?
Adrenergic beta-Agonists
1
1998
134
0.140
 Why?
American Heart Association
1
2019
306
0.140
 Why?
Collagen
1
2000
452
0.140
 Why?
Environment
2
2016
358
0.140
 Why?
Citrate (si)-Synthase
1
2017
60
0.130
 Why?
Microalgae
1
2016
10
0.130
 Why?
Ponds
1
2016
17
0.130
 Why?
Pharmacogenetics
2
2016
180
0.130
 Why?
Transcription Factors
2
2016
1719
0.130
 Why?
Prostate
1
1998
175
0.130
 Why?
Hypertension, Pulmonary
3
2012
1910
0.130
 Why?
Percutaneous Coronary Intervention
2
2019
480
0.130
 Why?
Aged, 80 and over
8
2020
7635
0.130
 Why?
Waste Disposal, Fluid
1
2016
49
0.130
 Why?
Administration, Intravenous
1
2017
155
0.130
 Why?
HIV Long Terminal Repeat
1
2016
11
0.130
 Why?
Global Health
2
2017
386
0.130
 Why?
Drug Design
1
2017
167
0.130
 Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
24
0.130
 Why?
Australia
4
2019
315
0.130
 Why?
Inflammation
6
2016
2837
0.130
 Why?
Simvastatin
2
2015
61
0.130
 Why?
Postoperative Complications
2
2019
2654
0.130
 Why?
Lipoproteins
2
2014
168
0.120
 Why?
Inflammation Mediators
2
2013
513
0.120
 Why?
HIV Envelope Protein gp120
1
2016
60
0.120
 Why?
Signal Transduction
1
2009
5079
0.120
 Why?
Clinical Trials as Topic
2
2018
1050
0.120
 Why?
Epigenesis, Genetic
1
2021
660
0.120
 Why?
Anti-Arrhythmia Agents
2
2012
114
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
197
0.120
 Why?
Platelet Aggregation Inhibitors
1
2019
463
0.120
 Why?
Heart Ventricles
6
2012
788
0.120
 Why?
ATP Binding Cassette Transporter 1
1
2015
10
0.120
 Why?
Recombinant Proteins
1
2018
1353
0.120
 Why?
Chromosomes, Human, Pair 16
1
2015
36
0.120
 Why?
Hospital Mortality
1
2019
911
0.120
 Why?
Vasodilation
2
2013
499
0.120
 Why?
Wireless Technology
1
2014
13
0.110
 Why?
Bacteria
2
2023
858
0.110
 Why?
Homeostasis
1
2018
621
0.110
 Why?
Linkage Disequilibrium
1
2015
268
0.110
 Why?
Smoking
2
2000
1627
0.110
 Why?
Stents
1
2018
527
0.110
 Why?
Transistors, Electronic
1
2014
9
0.110
 Why?
Serum Amyloid A Protein
3
2013
33
0.110
 Why?
Endovascular Procedures
1
2018
312
0.110
 Why?
Seawater
1
2014
31
0.110
 Why?
Heart Rate
5
2001
822
0.110
 Why?
Disease Progression
4
2018
2757
0.110
 Why?
Ions
1
2014
70
0.110
 Why?
Fresh Water
1
2014
57
0.110
 Why?
Phospholipases A
1
2014
102
0.100
 Why?
Metals, Heavy
1
2014
31
0.100
 Why?
Mendelian Randomization Analysis
1
2013
50
0.100
 Why?
Adult
13
2024
37929
0.100
 Why?
Commerce
1
2014
82
0.100
 Why?
Fasting
1
2015
281
0.100
 Why?
Acyl Coenzyme A
1
2013
31
0.100
 Why?
Heart Function Tests
1
2013
59
0.100
 Why?
Ultraviolet Rays
2
1992
396
0.100
 Why?
Ventricular Function, Right
1
1995
285
0.100
 Why?
Hydroxy Acids
1
2012
4
0.100
 Why?
Decanoic Acids
1
2012
8
0.100
 Why?
Ischemic Preconditioning, Myocardial
1
2012
29
0.100
 Why?
Monitoring, Physiologic
1
2014
275
0.100
 Why?
Talin
1
2012
9
0.100
 Why?
Potassium Channel Blockers
1
2012
37
0.100
 Why?
Glyburide
1
2012
32
0.100
 Why?
Cardiolipins
1
2013
85
0.100
 Why?
Retrospective Studies
6
2018
15657
0.100
 Why?
Nitric Oxide Synthase Type III
1
2013
204
0.100
 Why?
Biosensing Techniques
1
2014
129
0.090
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
22
0.090
 Why?
North America
3
2019
313
0.090
 Why?
Case-Control Studies
1
2019
3556
0.090
 Why?
Europe
3
2019
414
0.090
 Why?
Polymorphism, Genetic
1
2015
660
0.090
 Why?
Keto Acids
3
2019
13
0.090
 Why?
Prospective Studies
2
2021
7604
0.090
 Why?
Tissue Plasminogen Activator
2
2013
224
0.090
 Why?
Practice Guidelines as Topic
1
2019
1587
0.090
 Why?
DNA
2
2013
1459
0.090
 Why?
Arteries
1
2013
269
0.090
 Why?
Fractures, Bone
1
2016
380
0.090
 Why?
Hypertension
1
2000
1295
0.090
 Why?
Genetic Variation
1
2016
991
0.090
 Why?
Death, Sudden, Cardiac
1
2012
185
0.090
 Why?
MAP Kinase Signaling System
1
2013
320
0.090
 Why?
Manure
2
2023
8
0.080
 Why?
Electrocardiography
3
2011
629
0.080
 Why?
Myocardial Revascularization
3
2017
73
0.080
 Why?
Prejudice
1
2011
73
0.080
 Why?
United States Department of Veterans Affairs
3
2016
678
0.080
 Why?
Phosphorus
5
1995
97
0.080
 Why?
HIV-1
1
2016
864
0.080
 Why?
Polymers
1
2014
490
0.080
 Why?
Down-Regulation
2
2024
657
0.080
 Why?
Gene Expression Regulation
2
2013
2607
0.080
 Why?
RNA, Messenger
3
2015
2833
0.080
 Why?
Critical Care
1
2014
601
0.080
 Why?
Age Factors
3
2011
3295
0.070
 Why?
Macrophages
1
2016
1547
0.070
 Why?
Vitamin D Deficiency
1
1990
186
0.070
 Why?
Feeding Behavior
1
2014
654
0.070
 Why?
Vascular Diseases
2
2022
243
0.070
 Why?
Neoplasms
1
2023
2671
0.070
 Why?
MicroRNAs
1
2015
692
0.070
 Why?
Glomerular Filtration Rate
2
2025
746
0.070
 Why?
Ventricular Pressure
1
2007
48
0.070
 Why?
Diabetes Mellitus
1
2016
1040
0.070
 Why?
Equipment Design
3
2014
522
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
366
0.070
 Why?
Vitamin D
3
2000
397
0.070
 Why?
Models, Biological
1
2014
1783
0.070
 Why?
Ultrasonography, Interventional
2
2018
141
0.070
 Why?
Kaplan-Meier Estimate
2
2020
889
0.060
 Why?
Angiomatosis
1
2006
5
0.060
 Why?
Survival Rate
1
2011
1972
0.060
 Why?
Hemangioma, Capillary
1
2006
13
0.060
 Why?
Reactive Oxygen Species
1
2009
622
0.060
 Why?
Lactic Acid
2
1998
305
0.060
 Why?
Angina Pectoris
2
2004
65
0.060
 Why?
Anti-Inflammatory Agents
1
2009
496
0.060
 Why?
Ultrasonography
1
2009
759
0.060
 Why?
Apolipoproteins E
1
2025
83
0.060
 Why?
Cerebrovascular Disorders
2
2017
96
0.060
 Why?
Liver
2
2024
1943
0.060
 Why?
Chronic Disease
1
2011
1793
0.060
 Why?
Sus scrofa
1
2004
52
0.060
 Why?
alpha-Tocopherol
1
2004
33
0.060
 Why?
Heterozygote
1
2025
293
0.060
 Why?
Arterial Occlusive Diseases
2
1982
83
0.060
 Why?
Administration, Oral
1
2007
816
0.060
 Why?
Vegetables
1
2025
157
0.060
 Why?
Linear Models
2
2013
849
0.060
 Why?
Antigen-Antibody Complex
1
2004
90
0.060
 Why?
CD40 Ligand
1
2004
41
0.060
 Why?
Pulse Wave Analysis
1
2025
272
0.060
 Why?
Least-Squares Analysis
1
2004
79
0.060
 Why?
Economics, Pharmaceutical
1
2003
9
0.050
 Why?
Multicenter Studies as Topic
2
2012
310
0.050
 Why?
Ergocalciferols
1
2003
13
0.050
 Why?
Muscular Diseases
1
2004
114
0.050
 Why?
Regional Blood Flow
3
1996
474
0.050
 Why?
Radiation-Sensitizing Agents
1
2003
43
0.050
 Why?
Tumor Cells, Cultured
3
2003
955
0.050
 Why?
Comorbidity
2
2019
1622
0.050
 Why?
Lactates
2
1994
85
0.050
 Why?
Guidelines as Topic
1
2005
275
0.050
 Why?
beta-Lactams
1
2023
33
0.050
 Why?
Death
2
2019
119
0.050
 Why?
Angiotensin Receptor Antagonists
1
2023
92
0.050
 Why?
Creatine Kinase
1
2022
79
0.050
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2023
201
0.050
 Why?
Pharmacogenomic Testing
1
2022
64
0.050
 Why?
Drug Resistance, Bacterial
1
2023
186
0.050
 Why?
Multivariate Analysis
2
2017
1509
0.050
 Why?
Verapamil
1
2001
41
0.040
 Why?
Goals
1
2022
170
0.040
 Why?
Organ Preservation Solutions
1
2001
45
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
30
0.040
 Why?
Receptors, Immunologic
1
2022
216
0.040
 Why?
Oxidation-Reduction
3
2012
1060
0.040
 Why?
Antioxidants
1
2004
584
0.040
 Why?
Ventricular Dysfunction
1
2000
15
0.040
 Why?
Myocardial Stunning
1
2000
5
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
19
0.040
 Why?
Collagenases
1
2000
25
0.040
 Why?
Hexamethonium
1
2000
4
0.040
 Why?
Atropine
1
2000
23
0.040
 Why?
Arrhythmias, Cardiac
1
2003
333
0.040
 Why?
Soil Microbiology
1
2023
218
0.040
 Why?
Dilatation, Pathologic
1
2000
62
0.040
 Why?
Vascular Stiffness
1
2025
494
0.040
 Why?
Louisiana
1
2000
29
0.040
 Why?
Liver Cirrhosis
1
2022
316
0.040
 Why?
Health Care Costs
1
2003
398
0.040
 Why?
Dipeptides
2
2012
50
0.040
 Why?
Pilot Projects
1
2025
1710
0.040
 Why?
Interleukin-6
3
2013
778
0.040
 Why?
Pericardium
1
2000
55
0.040
 Why?
Occupations
1
2000
49
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
132
0.040
 Why?
Placebo Effect
1
2019
25
0.040
 Why?
Cell Line
2
2016
2847
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
382
0.040
 Why?
Blood Chemical Analysis
1
2020
99
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
76
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
New Zealand
1
2019
56
0.040
 Why?
Antigens, CD
1
2022
521
0.040
 Why?
Insulin Antagonists
1
1998
8
0.040
 Why?
Ventricular Function
1
1999
61
0.040
 Why?
Logistic Models
1
2004
2074
0.040
 Why?
Hormone Antagonists
1
1998
34
0.040
 Why?
Hungary
1
2018
4
0.040
 Why?
Placebos
1
2019
199
0.040
 Why?
Somatostatin
1
1998
61
0.040
 Why?
Drug Combinations
1
2000
343
0.040
 Why?
Sex Characteristics
1
2024
762
0.040
 Why?
Pulmonary Artery
2
2006
1086
0.040
 Why?
Infusion Pumps
1
2018
32
0.040
 Why?
India
1
2019
195
0.040
 Why?
Israel
1
2018
56
0.040
 Why?
Netherlands
1
2018
88
0.040
 Why?
Microscopy, Electron
1
1999
443
0.040
 Why?
Florida
1
1998
107
0.040
 Why?
Elasticity
1
1999
197
0.040
 Why?
Protective Factors
1
2018
93
0.040
 Why?
Drug Interactions
1
2019
410
0.040
 Why?
Sex Factors
1
2024
2071
0.040
 Why?
Blood Flow Velocity
1
1999
413
0.030
 Why?
Selection Bias
1
2017
37
0.030
 Why?
Echocardiography, Transesophageal
1
1997
96
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
184
0.030
 Why?
Erythrocytes
1
2022
700
0.030
 Why?
Poverty Areas
1
2016
39
0.030
 Why?
Catheterization
1
1997
179
0.030
 Why?
Cardiac Catheterization
1
2000
530
0.030
 Why?
Urban Health
1
2016
92
0.030
 Why?
Chi-Square Distribution
1
2017
530
0.030
 Why?
Rural Health
1
2016
80
0.030
 Why?
Pharmacogenomic Variants
1
2016
35
0.030
 Why?
Drug Discovery
1
2017
142
0.030
 Why?
Viral Tropism
1
2016
31
0.030
 Why?
Internationality
1
2017
155
0.030
 Why?
Drug Industry
1
2017
111
0.030
 Why?
Receptors, CCR5
1
2016
56
0.030
 Why?
Albuminuria
1
2017
185
0.030
 Why?
Receptors, CXCR4
1
2016
86
0.030
 Why?
Troponin
2
2007
50
0.030
 Why?
CD4 Antigens
1
2016
141
0.030
 Why?
Attitude of Health Personnel
1
2004
1171
0.030
 Why?
Immunoglobulin M
2
2009
289
0.030
 Why?
Membrane Proteins
1
2022
1164
0.030
 Why?
Cognitive Dysfunction
1
2021
383
0.030
 Why?
Fatty Acids
1
1998
443
0.030
 Why?
Body Mass Index
1
2024
2389
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
141
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Genome-Wide Association Study
1
2022
1431
0.030
 Why?
Physicians
1
2004
910
0.030
 Why?
Receptors, LDL
1
2015
47
0.030
 Why?
Creatinine
1
2017
499
0.030
 Why?
Electromagnetic Radiation
1
2014
3
0.030
 Why?
Thrombolytic Therapy
1
1996
142
0.030
 Why?
Quality of Life
1
2007
2892
0.030
 Why?
Lidocaine
1
1994
42
0.030
 Why?
Myositis
1
2015
52
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
389
0.030
 Why?
Social Class
1
2016
282
0.030
 Why?
Adenosine
2
1994
225
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
90
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
30
0.030
 Why?
Electric Stimulation
1
1995
264
0.030
 Why?
Calibration
1
2014
146
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
131
0.030
 Why?
Osmolar Concentration
1
1994
171
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
137
0.030
 Why?
Analysis of Variance
1
2017
1316
0.030
 Why?
Seasons
1
2016
547
0.030
 Why?
Semiconductors
1
2014
40
0.030
 Why?
Stroke Volume
1
1997
612
0.030
 Why?
Adenosine Diphosphate
1
1994
79
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2000
1396
0.030
 Why?
Mice
3
2016
17787
0.030
 Why?
Pressure
1
2014
225
0.030
 Why?
NAD
1
1994
77
0.030
 Why?
Solutions
1
2014
168
0.030
 Why?
Glycine
1
1994
176
0.030
 Why?
Hyperglycemia
1
2017
347
0.030
 Why?
Mitochondria, Heart
1
1994
102
0.030
 Why?
Patient Outcome Assessment
1
2014
131
0.030
 Why?
Perioperative Period
1
2013
56
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
39
0.030
 Why?
Materials Testing
1
2014
356
0.020
 Why?
Oxidative Phosphorylation
1
1994
193
0.020
 Why?
Binding Sites
1
2016
1303
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
141
0.020
 Why?
Heparin
1
1994
261
0.020
 Why?
Immunoglobulin G
2
2009
893
0.020
 Why?
Nutrition Surveys
1
2014
266
0.020
 Why?
Dogs
3
1984
413
0.020
 Why?
Anti-Bacterial Agents
1
2023
1809
0.020
 Why?
Actinin
1
2012
13
0.020
 Why?
South Africa
1
2013
222
0.020
 Why?
Weight Gain
1
2016
519
0.020
 Why?
Socioeconomic Factors
1
2016
1289
0.020
 Why?
Patient Selection
1
1996
696
0.020
 Why?
Mathematics
1
1992
103
0.020
 Why?
Cardiac Output, Low
1
1992
66
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
345
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
385
0.020
 Why?
Vascular Resistance
2
1984
375
0.020
 Why?
Reperfusion
1
1991
40
0.020
 Why?
Perfusion
1
1992
213
0.020
 Why?
Biopsy
1
1995
1129
0.020
 Why?
Disease-Free Survival
1
2013
686
0.020
 Why?
Cross-Sectional Studies
2
2014
5472
0.020
 Why?
Anticoagulants
1
1996
664
0.020
 Why?
Poisson Distribution
1
2011
75
0.020
 Why?
Georgia
1
2011
86
0.020
 Why?
Constriction
1
1990
47
0.020
 Why?
Vitamin D-Binding Protein
1
1990
15
0.020
 Why?
Patient Discharge
1
2017
897
0.020
 Why?
Cells, Cultured
1
1998
4193
0.020
 Why?
Cognition Disorders
1
2014
496
0.020
 Why?
Alleles
1
2013
891
0.020
 Why?
Hypoglycemia
1
2015
445
0.020
 Why?
Regression Analysis
1
1992
1024
0.020
 Why?
Cell Division
2
2003
794
0.020
 Why?
Autoantibodies
2
2009
1496
0.020
 Why?
Young Adult
2
2016
13209
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
82
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2189
0.020
 Why?
Educational Status
1
2011
470
0.020
 Why?
Thromboembolism
1
2009
119
0.020
 Why?
Densitometry
1
2007
36
0.020
 Why?
Environmental Exposure
1
1992
579
0.020
 Why?
Spectrin
1
2007
14
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
38
0.020
 Why?
Databases, Factual
1
2013
1357
0.020
 Why?
Poverty
1
2011
521
0.020
 Why?
Heart Diseases
1
1990
346
0.020
 Why?
Calcium-Binding Proteins
1
2007
218
0.020
 Why?
Kidney
1
2014
1468
0.020
 Why?
ROC Curve
1
2007
554
0.020
 Why?
Fatal Outcome
1
2006
303
0.010
 Why?
Apolipoprotein B-100
1
2004
10
0.010
 Why?
Protein Processing, Post-Translational
1
2007
465
0.010
 Why?
Aminophylline
1
1984
10
0.010
 Why?
Vasomotor System
1
1984
47
0.010
 Why?
Solubility
1
2004
245
0.010
 Why?
Mice, Inbred C57BL
1
2014
5757
0.010
 Why?
Radiation, Ionizing
1
2003
80
0.010
 Why?
DNA, Neoplasm
1
2003
164
0.010
 Why?
Health Care Surveys
1
2004
565
0.010
 Why?
Immunohistochemistry
1
2006
1738
0.010
 Why?
Electrophysiology
1
1982
217
0.010
 Why?
Odds Ratio
1
2004
1070
0.010
 Why?
Echocardiography
2
1997
642
0.010
 Why?
Vascular Surgical Procedures
1
2004
303
0.010
 Why?
Blotting, Western
1
2003
1226
0.010
 Why?
Mixed Function Oxygenases
1
2000
40
0.010
 Why?
Chemoprevention
1
2000
92
0.010
 Why?
Adolescent
2
2016
21513
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
560
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2000
976
0.010
 Why?
Thorax
1
1997
50
0.010
 Why?
Phosphorus Isotopes
1
1995
7
0.010
 Why?
Infusions, Parenteral
1
1994
40
0.010
 Why?
Basal Metabolism
1
1994
61
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
87
0.010
 Why?
Apoptosis
1
2003
2553
0.010
 Why?
Substrate Specificity
1
1995
372
0.010
 Why?
T-Lymphocytes
1
2002
1996
0.010
 Why?
Glycolysis
1
1995
321
0.010
 Why?
Lung
1
2006
4060
0.010
 Why?
Stimulation, Chemical
1
1992
59
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2486
0.010
 Why?
Diphosphoglyceric Acids
1
1991
4
0.010
 Why?
Radio Waves
1
1991
18
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Cardiomegaly
1
1990
175
0.000
 Why?
Rats
1
1997
5647
0.000
 Why?
Heart Block
1
1984
42
0.000
 Why?
Theophylline
1
1984
67
0.000
 Why?
Oxygen
1
1984
931
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3566
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (580) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)